CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Comparison of plasma methylated SEPT9 screening marker in both left- and right-sided colon cancer to GFOBT and CEA results
DOI 10.1055/s-0032-1312435
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Tóth, A Kalmár, VÁ Patai, A Schöller, K Leiszter, G Valcz, B Wichmann, F Sipos, R Stöhr, H Golcher, V Schellerer, Z Nagy, B Barták, B Molnár, Z Tulassay
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Methylated SEPT9 (mSEPT9) DNA was found as a sensitive and specific biomarker for colorectal cancer (CRC) from peripheral blood. Many aspects of the biology of mSEPT9 in the plasma of CRC patients have already been explored, including relationship to CRC location, guaiac-based faecal occult blood test (gFOBT) positivity and other blood-based tumor markers. Aims: 1, Determine the sensitivity of mSEPT9 for…
Zitieren
Zitierempfehlung
K Tóth, A Kalmár, VÁ Patai, A Schöller, K Leiszter, G Valcz, B Wichmann, F Sipos, R Stöhr, H Golcher, V Schellerer, Z Nagy, B Barták, B Molnár, Z Tulassay (2012) Comparison of plasma methylated SEPT9 screening marker in both left- and right-sided colon cancer to GFOBT and CEA results. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0032-1312435
Mit CareLit weiterarbeiten